These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 8270435

  • 1. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
    Dorie MJ, Menke D, Brown JM.
    Int J Radiat Oncol Biol Phys; 1994 Jan 01; 28(1):145-50. PubMed ID: 8270435
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide in enhancing the response of a human tumor xenograft to fractionated irradiation.
    el-Said A, Menke D, Dorie MJ, Brown JM.
    Radiat Oncol Investig; 1999 Jan 01; 7(3):163-9. PubMed ID: 10406058
    [Abstract] [Full Text] [Related]

  • 3. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ, Horsman MR, Siemann DW.
    Br J Cancer; 1993 Aug 01; 68(2):269-73. PubMed ID: 8347481
    [Abstract] [Full Text] [Related]

  • 4. Radiosensitizing effect of nicotinamide and carbogen combined in fractionated pions or x-rays in SCCVII tumors.
    Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
    Radiat Med; 1995 Aug 01; 13(6):291-5. PubMed ID: 8850370
    [Abstract] [Full Text] [Related]

  • 5. Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and carbogen: analysis by micronucleus assay.
    Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
    Radiother Oncol; 1993 Aug 01; 28(2):162-7. PubMed ID: 8248558
    [Abstract] [Full Text] [Related]

  • 6. The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing.
    Siemann DW, Horsman MR, Chaplin DJ.
    Radiother Oncol; 1994 May 01; 31(2):117-22. PubMed ID: 8066190
    [Abstract] [Full Text] [Related]

  • 7. Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumors.
    Brown JM, Lemmon MJ.
    Cancer Res; 1990 Dec 15; 50(24):7745-9. PubMed ID: 2253217
    [Abstract] [Full Text] [Related]

  • 8. Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide: therapeutic gain comparisons for fractionated x-ray schedules.
    Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp J.
    Radiother Oncol; 1996 Apr 15; 39(1):53-64. PubMed ID: 8735494
    [Abstract] [Full Text] [Related]

  • 9. Carbogen breathing after irradiation enhances the effectiveness of tirapazamine in SiHa tumors but not SCCVII tumors in mice.
    Minchinton AI, Tonn DA, Sutherland DP, Kyle AH.
    Radiat Res; 2002 Jul 15; 158(1):94-100. PubMed ID: 12071808
    [Abstract] [Full Text] [Related]

  • 10. Comparison of in vivo efficacy of hypoxic cytotoxin tirapazamine and hypoxic cell radiosensitizer KU-2285 in combination with single and fractionated irradiation.
    Shibata T, Shibamoto Y, Sasai K, Oya N, Murata R, Takagi T, Hiraoka M, Abe M.
    Jpn J Cancer Res; 1996 Jan 15; 87(1):98-104. PubMed ID: 8609056
    [Abstract] [Full Text] [Related]

  • 11. Reactions of tumors and normal tissues in mice to irradiation in the presence and absence of a perfluorochemical emulsion.
    Rockwell S, Mate TP, Irvin CG, Nierenburg M.
    Int J Radiat Oncol Biol Phys; 1986 Aug 15; 12(8):1315-8. PubMed ID: 3093416
    [Abstract] [Full Text] [Related]

  • 12. Effects of carbogen plus fractionated irradiation on KHT tumor oxygenation.
    Fenton BM.
    Radiother Oncol; 1997 Aug 15; 44(2):183-90. PubMed ID: 9288848
    [Abstract] [Full Text] [Related]

  • 13. Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
    Chaplin DJ, Horsman MR, Aoki DS.
    Br J Cancer; 1991 Jan 15; 63(1):109-13. PubMed ID: 1846549
    [Abstract] [Full Text] [Related]

  • 14. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells.
    Zeman EM, Brown JM, Lemmon MJ, Hirst VK, Lee WW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1239-42. PubMed ID: 3744945
    [Abstract] [Full Text] [Related]

  • 15. Fractionated irradiation combined with carbogen breathing and nicotinamide of two human glioblastomas grafted in nude mice.
    Sun LQ, Coucke PA, Mirimanoff RO, Buchegger F.
    Radiat Res; 2001 Jan 15; 155(1 Pt 1):26-31. PubMed ID: 11121212
    [Abstract] [Full Text] [Related]

  • 16. 4-[3-(2-Nitro-1-imidazolyl)propylamino]-7-chloroquinoline hydrochloride (NLCQ-1), a novel bioreductive agent as radiosensitizer in vitro and in vivo: comparison with tirapazamine.
    Papadopoulou MV, Ji M, Rao MK, Bloomer WD.
    Oncol Res; 2001 Jan 15; 12(8):325-33. PubMed ID: 11589303
    [Abstract] [Full Text] [Related]

  • 17. Middle dose rate irradiation in combination with carbogen inhalation selectively and more markedly increases the responses of SCCVII tumors.
    Ono K, Masunaga S, Akuta K, Akaboshi M.
    Int J Radiat Oncol Biol Phys; 1994 Apr 30; 29(1):81-5. PubMed ID: 8175449
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single- and multifraction irradiation.
    Fenton BM, Lord EM, Paoni SF.
    Radiat Res; 2000 Jan 30; 153(1):75-83. PubMed ID: 10630980
    [Abstract] [Full Text] [Related]

  • 19. Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
    Horsman MR, Overgaard J.
    Radiother Oncol; 2004 Mar 30; 70(3):301-9. PubMed ID: 15064017
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.